Bad for ↓
The 10-year real yield (the return after inflation) jumped 24 basis points in 5 days to 2.85%. That rare 2.94 standard deviation move looks like a lasting shift. Healthcare stocks are favored as safe havens, but richly valued device makers like Intuitive Surgical carry rate risk investors are overlooking.
Source: FRED ↗
Real yields, the return on 10-year Treasuries after inflation, rose 24 basis points in 5 days to 2.85%. That 6-month high, a near-3 standard deviation move, points to a lasting shift. Each 25 basis point rise cuts fair-value multiples by roughly 5-7% for companies whose value lies 10+ years out. Growth tech is expected to take the hit, and that view is crowded. Healthcare has been treated as a safe place, but the sector hides a split. Managed care and generic drug makers are truly defensive. Richly valued device makers like Intuitive Surgical (ISRG) are growth stocks with a healthcare label. Intuitive Surgical sits in the healthcare sector fund, not technology, so it has not fallen with other rate-sensitive stocks. That gap may close once investors stop treating it as rate-proof.
Investors see healthcare as a safe place to hide as rates rise, and money is moving into the sector. Intuitive Surgical (ISRG) in particular is held as a steady growth compounder with pricing power and a strong moat that shields it from rate cycles.
Why that may be wrong
Intuitive Surgical (ISRG) sits in the healthcare sector fund, and rule-based investors rotating out of financials and utilities treat it as a safe healthcare stock. Their screens (low beta, meaning the stock moves less than the market, and steady earnings) do not tell a managed care company with near-term cash flows from a surgical robot maker whose value lies 15 years out. So defensive money is lifting the stock just as higher real yields cut its fair value. This split within healthcare also spreads slowly. Generalist fund managers rarely test medical device stocks against real yields the way they test software.
The link fails if real yields reverse sharply, say if the 10-year inflation-protected Treasury (TIPS) yield falls back below 2.50% within 3-4 weeks. That would suggest the 24 basis point jump was a technical overshoot, not a lasting shift. Watch for a strong TIPS auction, with bids above 2.4 times the amount offered, or a Fed statement that caps real rate expectations. Either would remove the reason for valuations to shrink.
The 24 basis point move in 5 days may be noise. A single large auction of inflation-protected Treasuries (TIPS) or month-end index rebalancing could cause it, since these bonds trade thinly. The weakest step is the second. Intuitive Surgical (ISRG) has dependable earnings, and its installed base of robots brings recurring revenue that partly offsets its rate sensitivity. Its valuation may shrink less than a pure cash flow model implies. If the Fed signals a pause or cut at its October 2026 meeting, real yields could drop sharply. A 10-year TIPS yield back below 2.55% on any day in the next two weeks would mark the move as technical.
In the third quarter of 2023, 10-year real yields rose from about 1.5% to about 2.5% over roughly 8 weeks, a similar shift. Intuitive Surgical (ISRG) trailed the S&P 500 by about 12% over the next 6 weeks as long-dated healthcare valuations fell. The healthcare sector fund held up fairly well, because managed care and drug makers offset the device makers' losses. In late 2021, as real yields began rising from deeply negative levels, richly valued device makers such as Intuitive Surgical, Dexcom and Insulet fell 15-25% over 3-4 months and led healthcare lower. The broad healthcare index fell only 5-8%, a split the sector fund hides.
10-year real yields jumped 24 basis points in 5 days to 2.85%, a 2.94 standard deviation move to the top of the 6-month range. That raises the after-inflation rate used to value profits far in the future.
A higher real discount rate shrinks the present value of profits weighted toward the future. Richly valued companies, with value lying 10+ years out, face fair-value cuts of 5-10% for every 25 basis points of lasting rise in real yields.
Intuitive Surgical (ISRG), richly valued with value stretching 15 years out, is held as a defensive healthcare stock by investors who treat the healthcare sector as one block. That hides its rate risk. It has not fallen with software and other growth stocks, a gap likely to close once generalist fund managers test their medical device holdings against real yields.
No comments yet.
Sign in to comment